Anti-inflammatory lipoxin A4 is an endogenous allosteric enhancer of CB1 cannabinoid receptor. Cannabinoid receptors and their ligands: beyond CB1 and CB2. International Union of Basic and Clinical Pharmacology. Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors. Molecular characterization of a peripheral receptor for cannabinoids.
Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nucleotide sequence of a human cannabinoid receptor cDNA. Determination and characterization of a cannabinoid receptor in rat brain. Structure–activity relationships defining the ACD-tricyclic cannabinoids: cannabinoid receptor binding and analgesic activity. Structure–activity relationships for cannabinoid receptor-binding and analgesic activity: studies of bicyclic cannabinoid analogs. Stereochemical effects of 11-OH-Δ 8-tetrahydrocannabinol-dimethylheptyl to inhibit adenylate cyclase and bind to the cannabinoid receptor. Involvement of Gi in the inhibition of adenylate cyclase by cannabimimetic drugs. Biochemistry of the response in neuroblastoma cell membranes. Cannabinoid inhibition of adenylate cyclase. Inhibition of neuroblastoma adenylate cyclase by cannabinoid and nantradol compounds. Pharmacology of the response in neuroblastoma cell membranes. Inhibition of adenylate cyclase mediated by α receptors. Regulation of adenylate cyclase of neuroblastoma x glioma hybrid cells by α-adrenergic receptors. Regulation of adenylate cyclase activity mediated by muscarinic acetylcholine receptors. Opiate receptors as regulators of adenylate cyclase. Enantiomeric cannabinoids: stereospecificity of psychotropic activity. Stereochemical requirements for cannabinoid activity. Emerging strategies for exploiting cannabinoid receptor agonists as medicines. The central neuropharmacology of psychotropic cannabinoids. Cannabinoid pharmacology: the first 66 years. The ring test: a quantitative method for assessing the 'cataleptic' effect of cannabis in mice. Pharmacokinetics and metabolism of Δ-1-tetrahydrocannabinol and other cannabinoids with emphasis on man. Recent advances in the chemistry and biochemistry of cannabis. Isolation, structure and partial synthesis of an active constituent of hashish. Cannabiswirkstoffe und Pharmacologie der Cannabinole. in The Bengal Dispensatory and Pharmacopoeia, 579 (Bishop's College Press, 1841).Īdams, R. in Cannabinoids as Therapeutic Agents, (ed.